Craig-Hallum Maintains Buy on Apyx Medical, Raises Price Target to $6
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
Craig-Hallum analyst Matthew Hewitt maintains Apyx Medical (NASDAQ:APYX) with a Buy and raises the price target from $5 to $6.
Craig-Hallum analyst Matthew Hewitt maintains Apyx Medical (NASDAQ:APYX) with a Buy and raises the price target from $5 to $6.